Last reviewed · How we verify
NCT03085212: SPA
Strategies for Pregnancy Achievement
NA trial testing Stress Free Now in Fertility Disorders in 40 participants. Participants enrolled and being followed up; not accepting new ones.
3 April 2019
Quick facts
| Lead sponsor | Courtney D.Lynch, PhD MPH |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 40 |
| Start date | 21 May 2017 |
| Primary completion | 3 April 2019 |
| Estimated completion | 31 December 2026 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Stress Free Now
Conditions studied
- Fertility Disorders — all drugs for Fertility Disorders →
- Psychological Stress — all drugs for Psychological Stress →
- Infertility — all drugs for Infertility →
- Infertility, Female — all drugs for Infertility, Female →
Sponsor
Courtney D.Lynch, PhD MPH
Who can join
Adults 18 to 34, female only, with Fertility Disorders or Psychological Stress. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of pilot study application is to build on the investigators' previous work that established the prospective association between stress and infertility. Specifically, the investigators hope to collect the preliminary data necessary to make them competitive to submit a R01 application to NIH for funding of a full-scale randomized controlled trial of an internet-based stress management program to examine its efficacy in decreasing stress and increasing pregnancy rates among women who have tried to get pregnant for 6-12 months without success. The program called Stress Free Now (SFN) was developed at the Cleveland Clinic and has been shown to be effective in lowering stress in a variety of populations. The program introduces concepts of mindfulness and cognitive-behavioral therapy to assist individuals in managing their stress levels. The intervention includes Internet-based interaction, daily emails and recommended relaxation practice of at least four days per week. Using targeted Facebook Ads and other recruitment modalities, the investigators will randomize 40 women ages 18-34 who have been trying to conceive for 6-12 months without success. The PI has been enrolling women in a similar study using this mechanism and has found it to be an efficient and cost-effective method of identifying potentially eligible individuals. Women will be randomized to SFN or a wait list control condition and will be followed for up to three months post-randomization with weekly journals as they try to conceive. The primary outcome of this randomized controlled trial is stress level, as measured by salivary alpha-amylase, while the secondary outcome will be pregnancy rate at the end of the three-month follow-up period.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03085212
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Fertility Disorders
Currently open trials in the same condition.
- NCT07017972 — Data Collection and Professional Simulated Use Study to Develop an Embryo Quality Artificial Intelligence (AI) Model · recruiting
- NCT06928337 — Data Collection Protocol for the Development of CHLOE-OQ, an AI Model for Assessing Oocytes Quality. · recruiting
- NCT06799507 — The Effect of Mindfulness-Based Lifestyle Support Program on Infertile Women · NA · recruiting
- NCT04663971 — Fertility and Pregnancy After Surgery IBD Audit · recruiting
- NCT05725512 — Prednisolone Administration in Patients With Unexplained REcurrent MIscarriages · Phase 4 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03085212 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Courtney D.Lynch, PhD MPH
- Last refreshed: 15 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03085212.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing